Deep Track Capital, LP 13D and 13G filings for Regulus Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 08:50 am Sale | 2025-06-30 | 13G | Regulus Therapeutics Inc. RGLS | Deep Track Capital, LP | 0 0.000% | -6,888,424 (Position Closed) | Filing |
| 2024-03-22 4:03 pm Purchase | 2024-03-12 | 13G | Regulus Therapeutics Inc. RGLS | Deep Track Capital, LP | 6,888,424 9.990% | 6,888,424 (New Position) | Filing |